Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

Haleon backed its full-year guidance despite ... healthcare business—which was spun out of GSK and is partly owned by Pfizer—said Thursday that revenue for the quarter was 2.78 billion pounds ...

Pfizer (NYSE: PFE) is in that group, in my opinion. The big drugmaker's forward dividend yield currently stands at just under ...

Pfizer Inc. Chief Executive Officer Albert Bourla said he’ll do “whatever it takes” to keep profits growing, including ...

Operator Good day, everyone, and welcome to Pfizer's third quarter 2024 earnings conference call. Today's call is being ...

Pfizer (NYSE:PFE) has reduced its ownership in the British consumer healthcare giant Haleon (NYSE:HLN) to 15% from 22.6% by selling £2.45B ($3.26B) worth of company shares, Reuters reported ...

Pfizer Inc. (NYSE: PFE) reported financial results for the third quarter of 2024 and raised its full-year 2024 guidance(1) ...

Pfizer, which is under pressure from activist investor Starboard, on Tuesday (Oct 29) topped third-quarter estimates as sales of its Covid-19 treatment Paxlovid blew past Wall Street expectations.

During the same period, the company received roughly $6.9 billion of net cash proceeds from the sale of its shares of Haleon, a consumer health joint venture with GSK. In Pfizer's Q3 earnings call ...